Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
ADIAL PHARMACEUTICALS, INC. (ADIL)
|
|
Balance Sheet |
|
|
|
Standardized | As Reported |
Annual | Quarterly |
|
In millions, except per share items | Jun-30-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Jun-30-21 | Mar-31-21 |
| 10-Q | | 10-Q | 10-Q | 10-Q | | 10-Q | 10-Q |
Assets |
Cash and equivalents | 1.2 | | 5.8 | 9.2 | 12.7 | | 5.2 | 5.6 |
Other current assets | 0.8 | | 1.0 | 0.8 | 0.3 | | 0.4 | 0.5 |
Total current assets | 2.0 | | 6.8 | 9.9 | 13.0 | | 5.6 | 6.2 |
Property, plant, and equipment, net | | | 0.1 | 0.1 | 0.1 | | 0.1 | 0.0 |
Intangibles | 0.0 | | 0.0 | 0.0 | 0.0 | | 0.0 | 0.0 |
Goodwill | | | 0.2 | 0.2 | 0.2 | | 0.1 | 0.1 |
Total assets | 3.8 | | 7.7 | 10.9 | 14.0 | | 8.1 | 8.6 |
|
Accounts payable | 0.1 | | 0.3 | 0.6 | 0.4 | | 0.5 | 0.6 |
Accrued expenses | 0.3 | | 1.0 | 1.0 | 1.7 | | 1.7 | 1.3 |
Short-term debt | 0.0 | | 0.0 | 0.0 | 0.0 | | 0.0 | 0.0 |
Short-term debt | | | | | | | | 0.0 |
Other current liabilities | 0.1 | | 0.1 | 0.2 | 0.1 | | 0.0 | 0.0 |
Total current liabilities | 0.5 | | 1.3 | 1.9 | 2.2 | | 2.2 | 2.0 |
Long-term debt | | | 0.8 | 0.9 | 0.9 | | 0.8 | 0.8 |
Other liabilities | | | 0.2 | 0.2 | 0.2 | | 0.2 | 0.2 |
Total liabilities | 0.5 | | 2.3 | 3.0 | 3.3 | | 3.2 | 3.0 |
|
Shareholders' equity [+] | 3.3 | | 5.4 | 8.0 | 10.7 | | 4.8 | 5.6 |
Paid-in capital | 68.8 | | 66.2 | 65.6 | 64.5 | | 45.6 | 42.0 |
Retained earnings | -65.5 | | -60.8 | -57.7 | -53.9 | | -40.8 | -36.4 |
Tangible shareholders' equity | 3.3 | | 5.2 | 7.7 | 10.5 | | 4.7 | 5.5 |
|